<DOC>
	<DOCNO>NCT02850809</DOCNO>
	<brief_summary>Multi-institutional registry cohort 310 patient biopsy-proven renal cell carcinoma treat Radiofrequency ablation . All patient include consecutively retrospectively center obtain required number patient follow 5 year .</brief_summary>
	<brief_title>Evaluation Efficacy Radiofrequency Treatment Renal Tumors</brief_title>
	<detailed_description>Radiofrequency ablation ( RFA ) renal cell carcinoma ( RCC ) actually use elderly patient small renal tumor ( diameter ≤ 4 cm ) present high risk surgery ( due co-morbidity ) and/or reduce renal function . RFA minimally invasive technique , consider alternative surgery limit morbidity preserve kidney function . The technique well know proven efficacy treatment small tumor . An enlargement indication RFA patient without contra-indication surgery depend efficacy technique . The main objective study evaluate local efficacy ablation base technical success , evaluation local cancer recurrence 5 year .</detailed_description>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>Patient treat percutaneous RFA Patient diagnosis renal mass maximum 3 mass treat ablation The diameter tumor must ≤ 40 mm , characterize CTscan MRI The histology tumor must biopsyproven patient must previous surgical ablation renal tumor ( ipsi contralateral ) Patient treat surgery laparoscopy Benign tumors No histological diagnosis ( biopsy previous treat renal carcinoma ) Patient secondary malignant site , ganglion visceral metastatic cell endovenous extend time RFA Patient diagnosis primary secondary extrarenal tumor location remission Patients treat antiangiogenic drug 6 month prior RFA .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>radiofrequency ablation</keyword>
	<keyword>complication</keyword>
</DOC>